Videos

Our discussion with Dr. Eugene Wright

Medical Director for Performance Improvement at the Charlotte Area Health Education Center and previously Consulting Associate in the departments of Medicine and Community and Family Medicine at Duke.

How does kidney care change between academic and rural environments?
How can biomarkers help identify patients with the greatest risk for kidney disease progression testing?
What about automatic opt-in for CKD testing?
Shouldn't we learn from other asymptomatic diseases?
How would you change CKD care if you were King for the Day?
How can we help "primary care" become more focused on chronic kidney disease
How is CKD a silent killer?
Should we be focusing on pre-diabetes or early-stage diabetes?
Why are we more focused on disease management vs disease prevention?
Why is type 2 diabetes the #1 risk factor-for developing chronic kidney disease?
What are the risk factors for developing type 2 diabetes?

Our discussion with Dr. Katherine Tuttle

Professor of Medicine in Nephrology at the University of Washington and the Executive Director for Research at Providence Inland Northwest Health.

Any progress being made with the Kidney Precision Medicine Project?
Why does the CDC 'bury' CKD under diabetic complications vs. as a standalone disease?
How would you explain the initial downward slope when using SGLT2i?
Tell us about the exciting new incidence study and its findings about where CKD starts in diabetes
How can we break the silence of chronic kidney disease?
Why is chronic kidney disease-known as a “silent killer”?

Our discussion with Dr. Holly Kramer

Professor of Public Health Sciences and Medicine in the Division of Nephrology and Hypertension at Loyola University Chicago.

How does patient care differ from within a hospital system vs a VA environment?
How can genetic variants and biomarkers work together to change the trajectory of CKD?
How can eating too much processed food lead to diabetes and CKD?
Do doctors know that CKD is a disease multiplier?
Do doctors know that CKD is a disease multiplier?
What's the relationship between blue shag carpets, reindeer costumes, and the need for early-stage kidney care?
Does the lack of early-stage CKD screening further drive the inequity gap?
Why is there no active recommendation for early-stage CKD screening-from the U.S. Preventive Taskforce?
What are the consequences for not screening early for CKD?

Our discussion with Keith Norris

Professor of Medicine, UCLA Division of General Internal Medicine and Health Services Research.

If you were King for the Day, how would you change kidney care in this country?
Do predictive models have potential in early-stage kidney care?
Where can kidney care have the most impact? At the PCP level.
Removing Race from Kidney Function Formulas: Is it a Scientific Justice or Social Justice Issue?
Real Drivers of Kidney Care Disparities

Our discussion with Dr. Arshad Rahim

Chief Medical Officer & SVP, Population Health Mount Sinai Health System.

How does population health benefit chronic disease management?
Are population health and precision medicine at odds?